Dissecting loss of heterozygosity (LOH) in neurofibromatosis type 1-associated neurofibromas: Importance of copy neutral LOH-Reference-Cited by-同舟云学术

Dissecting loss of heterozygosity (LOH) in neurofibromatosis type 1-associated neurofibromas: Importance of copy neutral LOH

Published:2010-12-22 Issue:1 Volume:32 Page:78-90
ISSN:1059-7794
Container-title:Human Mutation
language:en
Short-container-title:Hum. Mutat.

Author:

Garcia-Linares Carles,Fernández-Rodríguez Juana,Terribas Ernest,Mercadé Jaume,Pros Eva,Benito Llúcia,Benavente Yolanda,Capellà Gabriel,Ravella Anna,Blanco Ignacio,Kehrer-Sawatzki Hildegard,Lázaro Conxi,Serra Eduard

Publisher

Wiley

Subject

Genetics(clinical),Genetics

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/humu.21387/fullpdf

Reference47 articles.

1. Mutations affecting mRNA splicing are the most common molecular defects in patients with neurofibromatosis type 1;Ars;Hum Mol Genet,2000

2. SNP arrays in heterogeneous tissue: highly accurate collection of both germline and somatic genetic information from unpaired single tumor samples;Assie;Am J Hum Genet,2008

3. Role of homologous recombination in carcinogenesis;Bishop;Exp Mol Pathol,2003

4. Penetrance and variability in neurofibromatosis: a genetic study of 60 families;Carey;Birth Defects Orig Artic Ser,1979

5. Expression of recessive alleles by chromosomal mechanisms in retinoblastoma;Cavenee;Nature,1983

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Comprehensive Overview of NF1 Mutations in Iranian Patients;NeuroMolecular Medicine;2024-07-02

2. A platform for rapid patient-derived cutaneous neurofibroma organoid establishment and screening;Cell Reports Methods;2024-05

3. Unbalancing cAMP and Ras/MAPK pathways as a therapeutic strategy for cutaneous neurofibromas;JCI Insight;2024-01-04

4. Breast cancer risk inNF1-deleted patients;Journal of Medical Genetics;2023-12-22

5. Molecular underpinnings and environmental drivers of loss of heterozygosity in Drosophila intestinal stem cells;Cell Reports;2023-12